{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:35:50Z","timestamp":1778056550003,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Pacing and Electrophysiology Journal"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ipej.2020.08.002","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T19:09:32Z","timestamp":1597518572000},"page":"261-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of peri-procedural anticoagulation with rivaroxaban and apixaban during radiofrequency ablation of atrial fibrillation"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9709-0203","authenticated-orcid":false,"given":"Jayasree","family":"Pillarisetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhu","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamatha","family":"Vodapally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulasi","family":"Annapureddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maruthsakhi","family":"Molugu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donita","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudharani","family":"Bommana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhea","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghuveer","family":"Dendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhanunjaya","family":"Lakkireddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ipej.2020.08.002_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/europace\/eum120","volume":"9","author":"Calkins","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.ipej.2020.08.002_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/clc.20759","article-title":"Cost burden of cardiovascular hospitalization and mortality in ATHENA like patients with atrial fibrillation\/atrial flutter in the United States","volume":"33","author":"Naccarelli","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ipej.2020.08.002_bib3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1540-8167.2008.01181.x","article-title":"Complications of catheter ablation for atrial fibrillation: incidence and predictors","volume":"19","author":"Spragg","year":"2008","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ipej.2020.08.002_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1253\/circj.CJ-08-1097","article-title":"Complications in the catheter ablation of atrial fibrillation: incidence and management","volume":"73","author":"Takahashi","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.ipej.2020.08.002_bib5","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.thromres.2009.11.031","article-title":"Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation","volume":"126","author":"Vazquez","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.ipej.2020.08.002_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11886-010-0153-2","article-title":"Thromboembolic risk and anticoagulation strategies in patients undergoing catheter ablation for atrial fibrillation","volume":"13","author":"Viles-Gonzalez","year":"2011","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.ipej.2020.08.002_bib7","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1161\/CIRCULATIONAHA.109.921320","article-title":"Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio","volume":"121","author":"Di Biase","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ipej.2020.08.002_bib8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/europace\/eur038","article-title":"Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment","volume":"13","author":"Hakalahti","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.ipej.2020.08.002_bib9","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.hrthm.2009.07.007","article-title":"Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy","volume":"6","author":"Hussein","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ipej.2020.08.002_bib10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ipej.2020.08.002_bib11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ipej.2020.08.002_bib12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ipej.2020.08.002_bib13","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jacc.2011.12.014","article-title":"Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry","volume":"59","author":"Lakkireddy","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ipej.2020.08.002_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.hrthm.2012.12.011","article-title":"Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation","volume":"10","author":"Kim","year":"2013","journal-title":"Heart Rhythm"},{"issue":"17","key":"10.1016\/j.ipej.2020.08.002_bib15","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","article-title":"RE-CIRCUIT investigators. Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation","volume":"376","author":"Calkins","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ipej.2020.08.002_bib16","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2013.11.039","article-title":"Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients under- going radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry","volume":"63","author":"Lakkireddy","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ipej.2020.08.002_bib17","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.hrthm.2015.02.028","article-title":"Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: results from a multicenter study","volume":"12","author":"Di Biase","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ipej.2020.08.002_bib18","unstructured":"Bassiouny M, Saliba W, Rickard J, et\u00a0al. Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation. Circ"},{"issue":"3","key":"10.1016\/j.ipej.2020.08.002_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10840-013-9813-7","article-title":"Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrialfibrillation: a meta-analysis of observational studies","volume":"37","author":"Steinberg","year":"2013","journal-title":"J\u00a0Intervent Card Electrophysiol"},{"key":"10.1016\/j.ipej.2020.08.002_bib20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11936-013-0242-9","article-title":"Optimal strategies including use of newer anticoagulants for prevention of stroke and bleeding complications before, during, and after catheter ablation of atrial fibrillation and atrial flutter","volume":"15","author":"Bhave","year":"2013","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"28","key":"10.1016\/j.ipej.2020.08.002_bib21","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/eurheartj\/ehv177","article-title":"VENTURE-AF Investigators. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation","volume":"36","author":"Cappato","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ipej.2020.08.002_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijcard.2018.03.095","article-title":"Continuous and minimally-interrupted direct oral anticoagulant are both safe compared with vitamin K antagonist for atrial fibrillation ablation: an updated meta-analysis","volume":"262","author":"Ha","year":"2018","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ipej.2020.08.002_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/pace.12553","article-title":"Efficacy and safety of apixaban in the patients undergoing the ablation of atrial fibrillation","volume":"38","author":"Nagao","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.ipej.2020.08.002_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/pace.12771","article-title":"Meta-analysis of efficacy and safety of apixaban in patients undergoing catheter ablation for atrial fibrillation","volume":"39","author":"Lu","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ipej.2020.08.002_bib25","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/CIRCULATIONAHA.110.937953","article-title":"Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation","volume":"122","author":"Gaita","year":"2010","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ipej.2020.08.002_bib26","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.amjmed.2015.05.044","article-title":"National trends in ambulatory oral anticoagulant use","volume":"128","author":"Barnes","year":"2015","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.ipej.2020.08.002_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/europace\/euw368","article-title":"Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation","volume":"19","author":"Di Biase","year":"2017","journal-title":"Europace"}],"container-title":["Indian Pacing and Electrophysiology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972629220300887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972629220300887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:43:13Z","timestamp":1760852593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0972629220300887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0972629220300887"],"URL":"https:\/\/doi.org\/10.1016\/j.ipej.2020.08.002","relation":{},"ISSN":["0972-6292"],"issn-type":[{"value":"0972-6292","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of peri-procedural anticoagulation with rivaroxaban and apixaban during radiofrequency ablation of atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Indian Pacing and Electrophysiology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ipej.2020.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Indian Heart Rhythm Society. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}